An analysis of the CALLA study shows that ctDNA is detected an average of 5.5 months before radiographic progression.

New research suggests that an antibody-drug conjugate may offer practice-changing, patient-friendly treatment of blastic ...

The FDA granted de novo authorization to the first artificial intelligence (AI) program to support breast cancer risk ...

CHICAGO -- The bispecific T-cell engager tarlatamab (Imdelltra) significantly prolonged survival in the second-line treatment ...

Treating breast cancer patients with AstraZeneca's experimental pill camizestrant at the first sign of resistance to standard ...

“And you’re going to be treated at Memorial Sloan Kettering Cancer Center.” Jan Claire supported her young­er sister as she underwent chemo­therapy, surgery, and radiation to treat triple negative ...

A clinical trial at MSK found that music therapy for cancer-related anxiety is as effective as cognitive behavioral therapy and produces long-lasting benefits. Dr. Kevin Liou presented the results of ...

A newly developed molecular imaging technique can identify multiple subtypes of triple-negative breast cancer (TNBC), ...

Immunotherapy combined with chemo can give people a fighting chance against stomach and esophageal cancers, a new clinical ...

When cancer spreads from a primary tumor to new sites throughout the body, it undergoes changes that increase its genetic ...

More than three decades ago, the U.S. Food and Drug Administration (FDA) approved Bacillus Calmette-Guérin (BCG) as the first ...

Music therapy appeared as effective as first-line cognitive behavioral therapy for reduction of anxiety among cancer ...